F. Tas Et Al. , "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma," TUMOR BIOLOGY , vol.34, no.6, pp.3529-3536, 2013
Tas, F. Et Al. 2013. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma. TUMOR BIOLOGY , vol.34, no.6 , 3529-3536.
Tas, F., Karabulut, S., Bilgin, E., Sen, F., Yildiz, I., Tastekin, D., ... Ciftci, R.(2013). Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma. TUMOR BIOLOGY , vol.34, no.6, 3529-3536.
Tas, Faruk Et Al. "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma," TUMOR BIOLOGY , vol.34, no.6, 3529-3536, 2013
Tas, Faruk Et Al. "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma." TUMOR BIOLOGY , vol.34, no.6, pp.3529-3536, 2013
Tas, F. Et Al. (2013) . "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma." TUMOR BIOLOGY , vol.34, no.6, pp.3529-3536.
@article{article, author={Faruk TAŞ Et Al. }, title={Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma}, journal={TUMOR BIOLOGY}, year=2013, pages={3529-3536} }